Lenvatinib in unresectable HCC

Lenvatinib in unresectable HCC

User Photo
obr

3 years
750 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Philip Philip, MD of Karmanos Cancer Institute discusses the use of lenvatinib in patients with unresectable hepatocellular carcinoma (HCC) at the 2017 Annual Meeting Annual Meeting in Chicago, IL.
Up Next Autoplay
>